NCT00135512View on ClinicalTrials.gov

Study Of 323U66 SR In Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

December 1, 2004

Primary Completion Date

May 28, 2007

Study Completion Date

May 28, 2007

Conditions
Depressive Disorder
Interventions
DRUG

bupropion hydrochloride

Study drug

Trial Locations (7)

814-0180

GSK Investigational Site, Fukuoka

651-1145

GSK Investigational Site, Hyōgo

228-0828

GSK Investigational Site, Kanagawa

861-8002

GSK Investigational Site, Kumamoto

332-0012

GSK Investigational Site, Saitama

160-0023

GSK Investigational Site, Tokyo

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY